Association of Dopamine-related Gene Alleles, Smoking Behavior and Decline in FEV₁ in Subjects with COPD: Findings from the Lung Health Study

References

• Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140(3 Pt 2):S82–84.
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1(6077):1645–1648.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 –The lung health study. JAMA 1994; 272: 1497–1505.
   PubMed Web of Science ®Google Scholar
• Scanlon PD, Connett JE, Waller L, Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: The Lung Health Study. Am J Respir Crit Care Med 2000; 161:381–390.
   PubMed Web of Science ®Google Scholar
• Pride NB. Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax 2001; 56 (Suppl 2): ii7–10.
   PubMedGoogle Scholar
• Jiménez-Ruiz CA, Masa F, Miravitlles M, Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119:1365–1370.
   PubMed Web of Science ®Google Scholar
• Buist AS, Connett JE, Miller RD, Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study): Baseline characteristics of randomized participants. Chest 1993; 103:1863–1872.
   PubMed Web of Science ®Google Scholar
• Noble EP, St. Jeor ST, Ritchie T, D2 dopamine receptor gene and cigarette smoking: A reward gene? Medical Hypotheses 1994; 42:257–260.
   PubMed Web of Science ®Google Scholar
• Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes: a review. Am J Med Genet (Neuropsychiatric Genetics) 2003; 116:103–125.
   Google Scholar
• Lerman C, Caporaso NE, Audrain J, Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999; 18:14–20.
   PubMed Web of Science ®Google Scholar
• Sabol SZ, Nelson ML, Fisher C, A genetic association for cigarette smoking behavior. Health Psychol 1999; 18:7–13.
   PubMed Web of Science ®Google Scholar
• Old JM, Davies KE. Prenatal diagnosis of Duchenne muscular dystrophy by DNA analysis. J Med Genet, 1986; 23: 556–559.
   PubMed Web of Science ®Google Scholar
• Saiki RK, Gelfand DH, Stoffer S, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239:487–491.
   PubMed Web of Science ®Google Scholar
• Noble EP, Noble RE, Ritchie T, D2 dopamine receptor gene and obesity. Int J Eat Disord 1994;15:205–17.
   PubMed Web of Science ®Google Scholar
• Vandenbergh DJ, Persico Am, Hawkins AL, Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14:1104–1106.
   PubMed Web of Science ®Google Scholar
• Crapo RD, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659–664.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Altose MD, Connett JE, Methacholine reactivity predicts changes in lung function over time in smokers with early COPD. Am J Respir Crit Care Med 1996; 153:1802–1811.
   PubMed Web of Science ®Google Scholar
• O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline: The Normative Aging Study. Am J Respir Crit Care Med 1995; 152:87–92.
   PubMed Web of Science ®Google Scholar
• Connett JE, Murray RP, Buist AS, Changes in smoking status affect women more than men: Results of the Lung Health Study. Am J Epidem 2003; 157:973–979.
   PubMed Web of Science ®Google Scholar
• Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982; 32:963–974.
   Google Scholar
• Hogg JC, Chu F, Utokaparch S, The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med; 2004; 350:2645–2653.
   PubMed Web of Science ®Google Scholar
• Silverman EK, Spira A, Pare PD. Genetics and genomics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:539–542.
   PubMedGoogle Scholar
• Hersh CP. Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics 2010; 11:237–247.
   PubMed Web of Science ®Google Scholar
• Takabatake N, Toriyama S, Igarashi A, A novel polymorphism in CDC6 is associated with the decline in lung function of ex-smokers in COPD. Biochem Biophys Res Commun 2009; 38:554–559.
   Google Scholar
• Missale C, Nash SR, Robinson SW. Dopamine receptors: from structure to function. Physiol Rev 1998; 78:189–225.
   PubMed Web of Science ®Google Scholar
• Bruzzone P, D'Andrea V, Motta C, Occurrence of dopaminergic (D(2)) receptros within the rabbit pulmonary circulation. Pulm Pharmacol Ther 2001; 15:393–398.
   Web of Science ®Google Scholar
• Jackson DM, Simpson WT. The effect of dopamine on the rapidly adapting receptors in the dog lung. Pulm Pharmacol Ther 2000; 13:39–42.
   PubMed Web of Science ®Google Scholar
• Xie GX, Jones K, Peroutka SJ, Detection of mRNAs and alternatively spliced transcripts of dopamine receptors in rat peripheral sensory and sympathetic ganglia. Brain Res 1998; 785:129–135.
   PubMed Web of Science ®Google Scholar
• Bierell MA, Crispino N, Hele DJ, Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD. Br J Pharmacol 2002; 136:620–628.
   PubMed Web of Science ®Google Scholar
• Bonnert RV, Brown RC, Chapman D, Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethy)-4-hydroxybenzothiasol-2(3H)-one analogues. J Med Chem 1998; 41:4915–4917.
   PubMed Web of Science ®Google Scholar
• Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis 1991; 143:1224–1230.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Washko GR, Foreman MG, Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132:464–470.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Curtis JL, Sciurba F, Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243–252.
   PubMed Web of Science ®Google Scholar
• Limosin, F, Gorwood P, Loze J-Y, Dubertet C, Gouya L, Deybach J-C, Adès J. Male limited association of the dopamine D2 gene Taq1A polymorphism and alcohol dependence. Am J Med Genet 2002; 112: 343–346.
   PubMed Web of Science ®Google Scholar
• Lopez-Castroman J, Vaquero-Lorenzo C, Mercedez Perez-Rodriguez M, Gender effect on association between DRD2 polymorphism and substance dependence in a Spanish sample. Drug Alcohol Depend 2009; 101: 210–212.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Timpson NJ, David SP, Association of the DRD2 geneTaq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tobacco Res 2009; 11: 64–76.
   PubMed Web of Science ®Google Scholar
• Lin J-J, Yueh K-C, Chang D-C, The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients. J Neurol Sci 2003; 209: 87–92.
   PubMed Web of Science ®Google Scholar
• Kaasinen V, Nagren K, Hietala J, Sex differences in extrastriatal dopamine D2− like receptors in the human brain. Am J Psych 2001; 158: 308–311.
   PubMed Web of Science ®Google Scholar
• Farde L, Hall H, Pauli S, Variability in D2− dopamine receptor density and affinity; a PET study with (κC) raclopride in man. Synapse 1995; 20:200–208.
   PubMed Web of Science ®Google Scholar
• Pohjalainen T, Rinne J, Nagren K, Sex differences in striatal dopamine D2 receptor binding characteristics in vivo. Am J Psych 1998; 155:768–773.
   PubMed Web of Science ®Google Scholar
• Noble EP, Blum K, Ritchie T, Allelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch Gen Psych 1991; 48:648–654.
   PubMed Web of Science ®Google Scholar
• Thompson J, Thomas N, Singleton A, D2 dopamine receptor gene (DRD2) Taq1A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997; 7:479–484.
   PubMedGoogle Scholar
• Pohjalainen T, Rinne JO, Nagren K, The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psych 1998; 3:256–260.
   PubMed Web of Science ®Google Scholar
• Jonsson EG, Nothen MM, Grunhage F, Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psych 1999; 4:290–296.
   PubMed Web of Science ®Google Scholar
• Ponce G, Perez-Gonzalez R, Aragues M, The ANKK1 Kinase Gene and psychiatric disorders. Neurotox Res 2009; 16:50–59.
   PubMed Web of Science ®Google Scholar